206 related articles for article (PubMed ID: 26255027)
1. The role of microenvironment and immunity in drug response in leukemia.
Bakker E; Qattan M; Mutti L; Demonacos C; Krstic-Demonacos M
Biochim Biophys Acta; 2016 Mar; 1863(3):414-426. PubMed ID: 26255027
[TBL] [Abstract][Full Text] [Related]
2. Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: From biology to therapeutic targeting.
Chiarini F; Lonetti A; Evangelisti C; Buontempo F; Orsini E; Evangelisti C; Cappellini A; Neri LM; McCubrey JA; Martelli AM
Biochim Biophys Acta; 2016 Mar; 1863(3):449-463. PubMed ID: 26334291
[TBL] [Abstract][Full Text] [Related]
3. Leukaemic stem cells: drug resistance, metastasis and therapeutic implications.
Wong RS; Cheong SK
Malays J Pathol; 2012 Dec; 34(2):77-88. PubMed ID: 23424769
[TBL] [Abstract][Full Text] [Related]
4. Galectin 3 as a guardian of the tumor microenvironment.
Ruvolo PP
Biochim Biophys Acta; 2016 Mar; 1863(3):427-437. PubMed ID: 26264495
[TBL] [Abstract][Full Text] [Related]
5. Targeting the bone marrow microenvironment in acute leukemia.
Karantanou C; Godavarthy PS; Krause DS
Leuk Lymphoma; 2018 Nov; 59(11):2535-2545. PubMed ID: 29431560
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of resistance and therapeutic prospect of leukemia mediated by signaling pathway in bone marrow microenvironment.
Zhang LP; Zhang MY; Liu WJ
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6419-6428. PubMed ID: 31378880
[TBL] [Abstract][Full Text] [Related]
7. "Caught in the net": the extracellular matrix of the bone marrow in normal hematopoiesis and leukemia.
Zanetti C; Krause DS
Exp Hematol; 2020 Sep; 89():13-25. PubMed ID: 32755619
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow neoplastic niche in leukemia.
Azizidoost S; Babashah S; Rahim F; Shahjahani M; Saki N
Hematology; 2014 Jun; 19(4):232-8. PubMed ID: 23905984
[TBL] [Abstract][Full Text] [Related]
9. The role of platelets in the tumor microenvironment: From solid tumors to leukemia.
Yan M; Jurasz P
Biochim Biophys Acta; 2016 Mar; 1863(3):392-400. PubMed ID: 26193075
[TBL] [Abstract][Full Text] [Related]
10. Tumor microenvironment (TME)-driven immune suppression in B cell malignancy.
Nicholas NS; Apollonio B; Ramsay AG
Biochim Biophys Acta; 2016 Mar; 1863(3):471-482. PubMed ID: 26554850
[TBL] [Abstract][Full Text] [Related]
11. The bone marrow niche in support of breast cancer dormancy.
Walker ND; Patel J; Munoz JL; Hu M; Guiro K; Sinha G; Rameshwar P
Cancer Lett; 2016 Sep; 380(1):263-71. PubMed ID: 26546045
[TBL] [Abstract][Full Text] [Related]
12. Selective elimination of leukemia stem cells: hitting a moving target.
Crews LA; Jamieson CH
Cancer Lett; 2013 Sep; 338(1):15-22. PubMed ID: 22906415
[TBL] [Abstract][Full Text] [Related]
13. The critical role of the bone marrow stromal microenvironment for the development of drug screening platforms in leukemia.
Panting RG; Kotecha RS; Cheung LC
Exp Hematol; 2024 May; 133():104212. PubMed ID: 38552942
[TBL] [Abstract][Full Text] [Related]
14. Tumour Cell Secretome in Chemoresistance and Tumour Recurrence.
Madden EC; Gorman AM; Logue SE; Samali A
Trends Cancer; 2020 Jun; 6(6):489-505. PubMed ID: 32460003
[TBL] [Abstract][Full Text] [Related]
15. Roles of NGAL and MMP-9 in the tumor microenvironment and sensitivity to targeted therapy.
Candido S; Abrams SL; Steelman LS; Lertpiriyapong K; Fitzgerald TL; Martelli AM; Cocco L; Montalto G; Cervello M; Polesel J; Libra M; McCubrey JA
Biochim Biophys Acta; 2016 Mar; 1863(3):438-448. PubMed ID: 26278055
[TBL] [Abstract][Full Text] [Related]
16. Targeting bone marrow lymphoid niches in acute lymphoblastic leukemia.
Uy GL; Hsu YM; Schmidt AP; Stock W; Fletcher TR; Trinkaus KM; Westervelt P; DiPersio JF; Link DC
Leuk Res; 2015 Dec; 39(12):1437-42. PubMed ID: 26467815
[TBL] [Abstract][Full Text] [Related]
17. Can inhibition of the SDF-1/CXCR4 axis eradicate acute leukemia?
Tavor S; Petit I
Semin Cancer Biol; 2010 Jun; 20(3):178-85. PubMed ID: 20637871
[TBL] [Abstract][Full Text] [Related]
18. Role of Microenvironment in Resistance to Therapy in AML.
Tabe Y; Konopleva M
Curr Hematol Malig Rep; 2015 Jun; 10(2):96-103. PubMed ID: 25921386
[TBL] [Abstract][Full Text] [Related]
19. Anti-myeloma activity of MELK inhibitor OTS167: effects on drug-resistant myeloma cells and putative myeloma stem cell replenishment of malignant plasma cells.
Stefka AT; Park JH; Matsuo Y; Chung S; Nakamura Y; Jakubowiak AJ; Rosebeck S
Blood Cancer J; 2016 Aug; 6(8):e460. PubMed ID: 27540718
[No Abstract] [Full Text] [Related]
20. [Recent research advance on bone marrow microenvironment-mediated leukemia drug resistant mechanism].
Fu B; Ling YJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Jun; 19(3):848-50. PubMed ID: 21729586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
